MBRX insider transactions
Moleculin Biotech Inc. (MBRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for MBRX
- SEC Form 4 filed by CSO Picker Donald H4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by EVP & CFO Foster Jonathan P.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by CEO and President Klemp Walter V4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Yan Joy4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Cermak Elizabeth4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Cannon Michael D4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Climaco John M4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director George Robert E.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Science Officer Picker Donald H converted options into 8,750 shares and covered exercise/tax liability with 2,131 shares, increasing direct ownership by 65% to 16,771 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- CEO and President Klemp Walter V converted options into 28,750 shares and covered exercise/tax liability with 7,001 shares, increasing direct ownership by 3% to 765,356 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Financial Officer Foster Jonathan P. converted options into 20,625 shares, increasing direct ownership by 5% to 303,189 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Financial Officer Foster Jonathan P. covered exercise/tax liability with 1,715 shares, bought $100,000 worth of shares (270,270 units at $0.37) and converted options into 7,039 shares, increasing direct ownership by 2,298% to 287,587 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- CEO and President Klemp Walter V bought $250,000 worth of shares (675,675 units at $0.37), converted options into 12,740 shares and covered exercise/tax liability with 3,104 shares, increasing direct ownership by 1,176% to 743,607 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Science Officer Picker Donald H converted options into 2,844 shares and covered exercise/tax liability with 693 shares, increasing direct ownership by 27% to 10,152 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Financial Officer Foster Jonathan P. converted options into 833 shares and covered exercise/tax liability with 203 shares, increasing direct ownership by 6% to 11,993 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- CEO and President Klemp Walter V converted options into 1,667 shares and covered exercise/tax liability with 406 shares, increasing direct ownership by 2% to 58,296 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Yan Joy4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Cermak Elizabeth4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Climaco John M4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director George Robert E.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Chief Science Officer Picker Donald H4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Director Cannon Michael D4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Foster Jonathan P.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by CEO and President Klemp Walter V4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- CEO and President Klemp Walter V converted options into 982 shares and covered exercise/tax liability with 240 shares, increasing direct ownership by 1% to 57,035 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Science Officer Picker Donald H converted options into 1,766 shares, increasing direct ownership by 18% to 8,001 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Financial Officer Foster Jonathan P. converted options into 4,329 shares and covered exercise/tax liability with 1,053 shares, increasing direct ownership by 41% to 11,363 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- CEO and President Klemp Walter V converted options into 8,990 shares and covered exercise/tax liability with 2,190 shares, increasing direct ownership by 14% to 56,293 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Science Officer Picker Donald H covered exercise/tax liability with 320 shares and converted options into 1,078 shares, increasing direct ownership by 13% to 6,759 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Financial Officer Foster Jonathan P. converted options into 2,712 shares and covered exercise/tax liability with 636 shares, increasing direct ownership by 35% to 8,087 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- CEO and President Klemp Walter V converted options into 3,750 shares and covered exercise/tax liability with 914 shares, increasing direct ownership by 6% to 49,493 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Chief Financial Officer Foster Jonathan P. converted options into 834 shares and covered exercise/tax liability with 196 shares, increasing direct ownership by 12% to 6,011 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- CEO and President Klemp Walter V converted options into 1,667 shares and covered exercise/tax liability with 406 shares, increasing direct ownership by 3% to 46,657 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Foster Jonathan P. bought $20,000 worth of shares (28,986 units at $0.69), increasing direct ownership by 56% to 80,556 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- George Robert E. bought $10,000 worth of shares (14,493 units at $0.69), increasing direct ownership by 8,678% to 14,660 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- Klemp Walter V bought $129,999 worth of shares (188,404 units at $0.69), increasing direct ownership by 38% to 680,880 units (SEC Form 4)4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Klemp Walter V4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Klemp Walter V4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Foster Jonathan P.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Klemp Walter V4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Picker Donald H4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Picker Donald H4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Foster Jonathan P.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Klemp Walter V4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Foster Jonathan P.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Klemp Walter V4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Yan Joy4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Cermak Elizabeth4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Climaco John M4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Cannon Michael D4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by George Robert E.4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4: Klemp Walter V bought $57,632 worth of shares (45,000 units at $1.28), increasing direct ownership by 12% to 409,890 units4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4: Klemp Walter V bought $25,866 worth of shares (22,500 units at $1.15), increasing direct ownership by 7% to 364,890 units4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4: Klemp Walter V bought $107,871 worth of shares (109,955 units at $0.98), increasing direct ownership by 47% to 342,390 units4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4: Klemp Walter V converted options into 13,204 shares and covered exercise/tax liability with 3,215 shares, increasing direct ownership by 4% to 232,435 units (Amendment)4/A - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4: Klemp Walter V converted options into 14,717 shares and covered exercise/tax liability with 3,584 shares, increasing direct ownership by 5% to 222,446 units (Amendment)4/A - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Klemp Walter V (Amendment)4/A - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4: Klemp Walter V converted options into 13,204 shares and covered exercise/tax liability with 3,215 shares, increasing direct ownership by 4% to 232,435 units4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4: Klemp Walter V converted options into 14,717 shares and covered exercise/tax liability with 3,584 shares, increasing direct ownership by 5% to 222,446 units4 - Moleculin Biotech, Inc. (0001659617) (Issuer)
- SEC Form 4 filed by Picker Donald H4 - Moleculin Biotech, Inc. (0001659617) (Issuer)